TY - JOUR
T1 - Development of medical device software for the screening and assessment of depression severity using data collected from a wristband-type wearable device
T2 - SWIFT study protocol
AU - the SWIFT collaborators
AU - Kishimoto, Taishiro
AU - Kinoshita, Shotaro
AU - Kikuchi, Toshiaki
AU - Bun, Shogyoku
AU - Kitazawa, Momoko
AU - Horigome, Toshiro
AU - Tazawa, Yuki
AU - Takamiya, Akihiro
AU - Hirano, Jinichi
AU - Mimura, Masaru
AU - Liang, Kuo Ching
AU - Koga, Norihiro
AU - Ochiai, Yasushi
AU - Ito, Hiromi
AU - Miyamae, Yumiko
AU - Tsujimoto, Yuiko
AU - Sakuma, Kei
AU - Kida, Hisashi
AU - Miura, Gentaro
AU - Kawade, Yuko
AU - Goto, Akiko
AU - Yoshino, Fumihiro
N1 - Funding Information:
This work was supported by the Japan Agency for Medical Research and Development (AMED) (Grant No. 21uk1024003h0001; Development of a software medical device that enables depression screening and severity assessment using wristband wearable device data). The funding source did not participate in the design of this study and will not have any hand in the study’s execution, analyses, or submission of results.
Publisher Copyright:
Copyright © 2022 Kishimoto, Kinoshita, Kikuchi, Bun, Kitazawa, Horigome, Tazawa, Takamiya, Hirano, Mimura, Liang, Koga, Ochiai, Ito, Miyamae, Tsujimoto, Sakuma, Kida, Miura, Kawade, Goto and Yoshino.
PY - 2022/12/21
Y1 - 2022/12/21
N2 - Introduction: Few biomarkers can be used clinically to diagnose and assess the severity of depression. However, a decrease in activity and sleep efficiency can be observed in depressed patients, and recent technological developments have made it possible to measure these changes. In addition, physiological changes, such as heart rate variability, can be used to distinguish depressed patients from normal persons; these parameters can be used to improve diagnostic accuracy. The proposed research will explore and construct machine learning models capable of detecting depressive episodes and assessing their severity using data collected from wristband-type wearable devices. Methods and analysis: Patients with depressive symptoms and healthy subjects will wear a wristband-type wearable device for 7 days; data on triaxial acceleration, pulse rate, skin temperature, and ultraviolet light will be collected. On the seventh day of wearing, the severity of depressive episodes will be assessed using Structured Clinical Interview for DSM-5 (SCID-5), Hamilton Depression Rating Scale (HAMD), and other scales. Data for up to five 7-day periods of device wearing will be collected from each subject. Using wearable device data associated with clinical symptoms as supervisory data, we will explore and build a machine learning model capable of identifying the presence or absence of depressive episodes and predicting the HAMD scores for an unknown data set. Discussion: Our machine learning model could improve the clinical diagnosis and management of depression through the use of a wearable medical device. Clinical trial registration: [https://jrct.niph.go.jp/latest-detail/jRCT1031210478], identifier [jRCT1031210478].
AB - Introduction: Few biomarkers can be used clinically to diagnose and assess the severity of depression. However, a decrease in activity and sleep efficiency can be observed in depressed patients, and recent technological developments have made it possible to measure these changes. In addition, physiological changes, such as heart rate variability, can be used to distinguish depressed patients from normal persons; these parameters can be used to improve diagnostic accuracy. The proposed research will explore and construct machine learning models capable of detecting depressive episodes and assessing their severity using data collected from wristband-type wearable devices. Methods and analysis: Patients with depressive symptoms and healthy subjects will wear a wristband-type wearable device for 7 days; data on triaxial acceleration, pulse rate, skin temperature, and ultraviolet light will be collected. On the seventh day of wearing, the severity of depressive episodes will be assessed using Structured Clinical Interview for DSM-5 (SCID-5), Hamilton Depression Rating Scale (HAMD), and other scales. Data for up to five 7-day periods of device wearing will be collected from each subject. Using wearable device data associated with clinical symptoms as supervisory data, we will explore and build a machine learning model capable of identifying the presence or absence of depressive episodes and predicting the HAMD scores for an unknown data set. Discussion: Our machine learning model could improve the clinical diagnosis and management of depression through the use of a wearable medical device. Clinical trial registration: [https://jrct.niph.go.jp/latest-detail/jRCT1031210478], identifier [jRCT1031210478].
KW - depression
KW - digital health
KW - machine learning
KW - personalized medicine
KW - wearables
UR - http://www.scopus.com/inward/record.url?scp=85145501780&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85145501780&partnerID=8YFLogxK
U2 - 10.3389/fpsyt.2022.1025517
DO - 10.3389/fpsyt.2022.1025517
M3 - Article
AN - SCOPUS:85145501780
SN - 1664-0640
VL - 13
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 1025517
ER -